Go Deep
Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,580 | 17.3 | 4.43 | 0.01 | 3,010.24 |
Jamjoom Pharmaceuticals Factory Company Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 445,311,046.0 | 481,384,557.0 | 304,572,009.0 | 396,221,795.0 |
| Net Profit | 137,627,266.0 | 168,213,822.0 | 68,072,519.0 | 132,024,076.0 |
| EPS | 2.0 | 2.4 | — | 1.9 |
Jamjoom Pharmaceuticals Factory Company Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 1,500,627,461.0 | 1,318,476,490.0 | 1,100,819,082.0 | 916,672,111.0 | — |
| Net Profit | 463,803,602.0 | 356,524,229.0 | 292,400,083.0 | 171,314,162.0 | — |
| EPS | 6.6 | 5.1 | 4.2 | 2.4 | — |
Jamjoom Pharmaceuticals Factory Company Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,045,559,618.0 | 1,771,634,588.0 | 1,654,165,587.0 | 1,407,817,125.0 | — |
| Total Liabilities | 328,792,450.0 | 281,026,830.0 | 249,836,618.0 | 191,553,799.0 | — |
| Total Equity | 1,716,767,168.0 | 1,490,607,758.0 | 1,404,328,969.0 | 1,216,263,326.0 | — |
Jamjoom Pharmaceuticals Factory Company Assets & Liabilities Breakdown (SAR millions)
What it owns — Dec 2025
Cash & short-term investments 17.5%Receivables 28.7%Inventory 12.1%Fixed assets (tangible) 35.1%Intangible assets 0.8%Long-term investments 3.4%Other assets 2.4%
How it's funded — Dec 2025
Long-term debt 0.6%Payables 1.9%Other liabilities 13.4%Shareholders' equity 83.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 358.1 | 262.3 | 289.4 | 146.3 |
| Receivables | 586.3 | 443.5 | 332.1 | 352.4 |
| Inventory | 248.2 | 270.9 | 233.9 | 131.9 |
| Fixed assets (tangible) | 718.5 | 673.9 | 698.3 | 705.0 |
| Intangible assets | 17.3 | 11.5 | 13.0 | 14.4 |
| Long-term investments | 68.8 | 57.5 | 36.1 | 0.3 |
| Other assets | 48.4 | 52.0 | 51.2 | 57.6 |
| Liabilities & equity | ||||
| Short-term debt | 3.2 | 0.3 | 0.2 | 0.2 |
| Long-term debt | 13.2 | 1.8 | 2.2 | 2.4 |
| Payables | 38.0 | 38.8 | 65.3 | 39.6 |
| Other liabilities | 274.3 | 240.1 | 182.1 | 149.3 |
| Shareholders' equity | 1,716.8 | 1,490.6 | 1,404.3 | 1,216.3 |
| Net tangible assets | 1,699.5 | 1,479.1 | 1,391.3 | 1,201.8 |
Jamjoom Pharmaceuticals Factory Company Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 406,288,106.0 | 263,301,598.0 | 295,915,464.0 | 229,325,821.0 | — |
| Investing Activities | -68,793,968.0 | -62,254,897.0 | -77,441,684.0 | -54,479,352.0 | — |
| Financing Activities | -243,146,218.0 | -217,306,411.0 | -70,235,177.0 | -149,127,785.0 | — |